Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.
Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania; Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Ann Thorac Surg. 2020 Oct;110(4):1235-1242. doi: 10.1016/j.athoracsur.2020.02.028. Epub 2020 Mar 18.
Reoperative cardiac surgery has been associated with increased morbidity and mortality. Large propensity-matched series comparing all first-time and redo cardiac operations are lacking. The primary objective of the current study was to provide detailed outcomes and risk factors for mortality and readmissions after reoperative cardiac surgery.
All patients who underwent cardiac surgery from 2011 to 2017 were included. Propensity matching yielded equitable cohorts. Multivariable Cox regression analysis was performed to identify independent predictors of 30-day, 1-year, and 5-year mortality and readmissions.
A total of 14,151 patients underwent cardiac surgery, of which 1700 (12%) had reoperative cardiac surgery. There were significantly (P < .001) more comorbidities in the reoperative cardiac surgery group. Propensity matching yielded 1696 patients in each cohort. After propensity matching, operative mortality (8.37% vs 6.07%; P = .01), blood product transfusion (54.7% vs 46.2%; P < .001), and prolonged ventilator requirements (>24 hours) (20% vs 17%; P = .02) were increased for the reoperative cohort. On multivariable analysis for propensity-matched cohorts, reoperation was an independent predictor of mortality at 30 days (hazard ratio [HR], 1.36; 95% confidence interval [CI], 1.05-1.75; P = .02), 1 year (HR, 1.30; 95% CI, 1.09-1.55; P = .004), and 5 years (HR, 1.30; 95% CI, 1.14-1.5; P = .002).
After risk-adjusting for baseline characteristics, the need for reoperation was an independent predictor of both short-term and long-term mortality after reoperative cardiac surgery. These data are relevant when considering alternative therapies such as percutaneous coronary or transcatheter valve interventions.
再次心脏手术与发病率和死亡率增加有关。缺乏比较所有初次和再次心脏手术的大型倾向匹配系列研究。本研究的主要目的是提供再次心脏手术后死亡率和再入院的详细结果和危险因素。
纳入 2011 年至 2017 年期间接受心脏手术的所有患者。进行倾向匹配以获得均衡队列。采用多变量 Cox 回归分析确定 30 天、1 年和 5 年死亡率和再入院的独立预测因素。
共有 14151 例患者接受了心脏手术,其中 1700 例(12%)进行了再次心脏手术。再次心脏手术组的合并症明显更多(P<.001)。倾向匹配后每个队列各有 1696 例患者。倾向匹配后,手术死亡率(8.37%比 6.07%;P<.001)、输血(54.7%比 46.2%;P<.001)和延长呼吸机需求(>24 小时)(20%比 17%;P=.02)在再次心脏手术组增加。在匹配倾向的队列的多变量分析中,再次手术是 30 天(危险比 [HR],1.36;95%置信区间 [CI],1.05-1.75;P=.02)、1 年(HR,1.30;95% CI,1.09-1.55;P=.004)和 5 年(HR,1.30;95% CI,1.14-1.5;P=.002)死亡的独立预测因素。
在对基线特征进行风险调整后,再次手术的需要是再次心脏手术后短期和长期死亡率的独立预测因素。这些数据在考虑替代疗法(如经皮冠状动脉或经导管瓣膜介入治疗)时是相关的。